The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped significantly in the last few years, a new survey shows.

The YouGov poll, released Friday, shows that at least 80 percent of respondents have heard at least "a little bit" about semaglutide, a medication used to treat Type 2 diabetes that also helps a user to shed weight.

In March 2023, only 60 percent of Americans were aware of the drug. A year later, in March 2024, that number had jumped to........

© The Hill